Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows promise for gene editing
- Posted on October 1, 2024
- By Bing News
- 2 Views
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows promise for gene editing
Scientists at St. Jude Children's Research Hospital have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors.
